12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 healthcare stocks during Wednesday's after-market session. Notable gainers include SINTX Techs (SINT), Petros Pharma (PTPI), and Bluejay Diagnostics (BJDX). Significant losers include Eyenovia (EYEN), Lucy Scientific Discovery (LSDI), and Monte Rosa Therapeutics (GLUE).
May 15, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bluejay Diagnostics shares increased by 10.22% to $0.58, with a market value of $1.5 million.
The stock's rise suggests positive investor sentiment, potentially due to recent news or market trends.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Petros Pharma shares rose 12.85% to $0.58, with a market value of $4.0 million.
The stock's rise indicates positive investor sentiment, possibly due to recent developments or market conditions.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
SINTX Techs shares increased by 22.2% to $0.16 during Wednesday's after-market session, following the release of their Q1 earnings report two days ago.
The significant price increase is likely due to positive market reaction to the Q1 earnings report released two days ago.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Eyenovia shares decreased by 20.8% to $0.84 following the release of their Q1 earnings report today.
The significant price drop is likely due to negative market reaction to the Q1 earnings report released today.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Monte Rosa Therapeutics shares declined by 10.18% to $4.7 following the release of their Q1 earnings report four days ago.
The price decline is likely due to negative market reaction to the Q1 earnings report released four days ago.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Lucy Scientific Discovery shares fell 15.48% to $0.43.
The stock's decline indicates negative investor sentiment, possibly due to recent developments or market conditions.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70